Platelet aggregation and coagulation and fibrinolysis parameters in both portal and systemic circulations in patients with cirrhosis and hepatocellular carcinoma

被引:4
作者
Kunihiro, N
Kawai, B
Sanjo, A
Osaka, K
Ohnishi, A
机构
[1] Jikei Univ, Daisan Hosp, Sch Med, Dept Internal Med, Komae, Tokyo 2018601, Japan
[2] Jikei Univ, Daisan Hosp, Sch Med, Dept Lab Med, Komae, Tokyo 2018601, Japan
关键词
platelet aggregation; prostaglandin; liver cirrhosis; coagulation; fibrinolysis;
D O I
10.1016/S1386-6346(00)00078-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A tendency to bleed and local vasodilation in the portal circulation are exacerbatory clinical factors in patients with liver cirrhosis. Esophageal variceal bleeding, in particular, is a frequent complication in these patients. Cirrhotic patients have been reported to show impairment of platelet aggregation and an activated fibrinolytic state, possibly with consequential lengthening of the bleeding time. Our previous study has demonstrated enhanced generation of PGI,, a vasodilating and anti-platelet aggregating hormone, ill the portal circulation of cirrhotic patients. In the present study, we compared the platelet aggregation and coagulation and fibrinolytic profiles in portal circulation with those in systemic circulation in twenty cirrhotic patients complicated with hepatocellular carcinoma. A portal blood sample was collected through a fine needle inserted percutaneously and guided ultrasonographically to the intrahepatic portal vein. Simultaneously, venous blood was drawn from a forearm vein as the systemic blood sample. Coagulation and fibrinolytic profiles were assessed by examining the extrinsic fibrinolytic system (tissue plasminogen activator (tPA), t-PA-plasminogen activator inhibitor complex), fibrinogen degeneration product, fibrinogen euglobulin lysis time, platelet count, and platelet aggregation elicited by ADP and collagen. Although fibrinolytic factors were activated in patients in the present study, there were no significant differences between the portal and systemic blood samples in all the coagulation and fibrinolytic parameters examined except for platelet aggregation. The curve of platelet aggregation response to collagen (1, 2, 10 mug/ml), but nor that to ADP, shifted significantly more to the right in the portal blood compared to the systemic blood (P < 0.05). This result suggested that the difference in prostaglandin generation reported previously, may cause the dissociation between collagen and ADP elicitation of platelet response in portal blood while there is no effect on other parameters in the coagulation and fibrinolytic profiles. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 22 条
[11]  
Kehrel B, 1998, BLOOD, V91, P491
[12]   SYNERGISM BETWEEN PLATELET AGGREGATING AGENTS - ROLE OF ARACHIDONATE PATHWAY [J].
KINLOUGHRATHBONE, RL ;
PACKHAM, MA ;
MUSTARD, JF .
THROMBOSIS RESEARCH, 1977, 11 (05) :567-580
[13]   ALTERED PLATELET-FUNCTION IN CIRRHOSIS OF THE LIVER - IMPAIRMENT OF INOSITOL LIPID AND ARACHIDONIC-ACID METABOLISM IN RESPONSE TO AGONISTS [J].
LAFFI, G ;
COMINELLI, F ;
RUGGIERO, M ;
FEDI, S ;
CHIARUGI, VP ;
LAVILLA, G ;
PINZANI, M ;
GENTILINI, P .
HEPATOLOGY, 1988, 8 (06) :1620-1626
[14]   PLATELET-ADHESIVENESS TO GLASS-BEADS IN LIVER-DISEASE [J].
LANGLEY, PG ;
HUGHES, RD ;
WILLIAMS, R .
ACTA HAEMATOLOGICA, 1982, 67 (02) :124-127
[15]  
MERSKEY C, 1969, P SOC EXP BIOL MED, V131, P871
[16]  
MONCADA S, 1978, PHARMACOL REV, V30, P293
[17]   Prostaglandin production in cirrhosis and portal hypertension - Experimental and clinical study [J].
Ohnishi, A ;
Harada, M ;
Matsuo, A ;
Kawai, B ;
Kunihiro, N ;
Tada, Y ;
Chau, T ;
Koizumi, F ;
Tanaka, T .
HEPATOLOGY RESEARCH, 1998, 10 (02) :131-141
[18]  
OWEN JS, 1981, J LIPID RES, V22, P423
[19]   THROMBOXANE-INDUCED PHOSPHATIDATE FORMATION IN HUMAN-PLATELETS - RELATIONSHIP TO RECEPTOR OCCUPANCY AND TO CHANGES IN CYTOSOLIC FREE CALCIUM [J].
POLLOCK, WK ;
ARMSTRONG, RA ;
BRYDON, LJ ;
JONES, RL ;
MACINTYRE, DE .
BIOCHEMICAL JOURNAL, 1984, 219 (03) :833-842
[20]  
RATNOFF OD, 1951, J LAB CLIN MED, V37, P316